BIN1 (O00499) variants and mutations
BIN1 (also known as O00499) is a human protein-coding gene encoding a myc box-dependent-interacting protein 1 protein. It shapes cellular membranes and participates in endocytosis, T-tubule organization in muscle, and membrane trafficking in neurons. Pathogenic variants can cause centronuclear myopathy, while common variation at the BIN1 locus is strongly associated with late-onset Alzheimer disease risk. This analysis covers 836 BIN1 variants and mutations. Of these, 80% have computational variant effect predictions. Disease context includes myopathy, centronuclear, 2, autosomal recessive centronuclear myopathy, and Alzheimer disease. Example BIN1 variants include A2V, E3D, and M4I.
Variant analysis overview
- Gene: BIN1
- Protein: O00499
- UniProt accession: O00499
- Organism: Homo sapiens
- Variants analyzed: 836
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 667 unspecified-consequence records; 1 stop retained variant; 85 missense variants; 67 synonymous variants; 6 frameshift variants; 4 stop-gained variants; 2 in-frame deletions; 4 splice-region variants; 1 in-frame insertions; 2 substitution
- Prediction scores: 669 variants have prediction scores (80% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: myopathy, centronuclear, 2, autosomal recessive centronuclear myopathy, Alzheimer disease, autosomal dominant centronuclear myopathy, centronuclear myopathy, dementia, neurodegenerative disease, Abnormality of the skeletal system, Lewy body dementia, memory impairment, late-onset Alzheimers disease, hypertensive disorder.
Protein structure and variant hotspots
- Protein features: 2 domains; 7 post-translational modification sites.
- Structural context: 409 variants have structural context.
- PTM context: 12 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable BIN1 variants
Examples include A2V, E3D, M4I, M4T, M4V, G5D, G5E, K7R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2V (p.Ala2Val), rs1681241176, ClinGen CA348376374, ClinVar RCV002810413, Ensembl rs1681241176, REVEL 0.18, CADD 26.70, Uncertain significance, Myopathy, centronuclear, 2
- E3D (p.Glu3Asp), rs558639756, ClinGen CA1857627, ClinVar RCV000559491, 1000Genomes rs558639756, REVEL 0.06, CADD 21.90, Uncertain significance, Myopathy, centronuclear, 2
- M4I (p.Met4Ile), gnomAD rs1681239868, REVEL 0.03, CADD 22.20
- M4T (p.Met4Thr), rs2467800316, ClinGen CA348376354, ClinVar RCV003510297, Uncertain significance, Myopathy, centronuclear, 2
- M4V (p.Met4Val), TOPMed rs1207990622, gnomAD rs1207990622, REVEL 0.04, CADD 22.80
- G5D (p.Gly5Asp), NCI-TCGA TCGA novel, REVEL 0.19, CADD 29.60, Variant assessed as somatic; moderate impact.
- G5E (p.Gly5Glu), rs2467800224, ClinGen CA2740095687, ClinVar RCV003840833, Uncertain significance, Myopathy, centronuclear, 2
- K7R (p.Lys7Arg), gnomAD rs1235619869, REVEL 0.20, CADD 25.10, Uncertain significance, Myopathy, centronuclear, 2
- T10K (p.Thr10Lys), rs1681237812, ClinGen CA348376283, ClinVar RCV001327643, TOPMed rs1681237812, Uncertain significance, Myopathy, centronuclear, 2
- T10M (p.Thr10Met), rs1681237812, ClinGen CA348376274, ClinVar RCV002700241, TOPMed rs1681237812, REVEL 0.18, CADD 31.00, Uncertain significance, Myopathy, centronuclear, 2
- N17K (p.Asn17Lys), rs2105378914, ClinGen CA348376190, ClinVar RCV001895160, Ensembl rs2105378914, REVEL 0.23, CADD 22.00, Uncertain significance, Myopathy, centronuclear, 2
- N17S (p.Asn17Ser), TOPMed rs1681237018
- V18L (p.Val18Leu), 1000Genomes rs566597765, ExAC rs566597765, TOPMed rs566597765, gnomAD rs566597765, REVEL 0.15, CADD 24.00, Uncertain significance
- V18M (p.Val18Met), rs566597765, ClinGen CA1857626, ClinVar RCV001071070, ClinVar RCV001760053, REVEL 0.17, CADD 23.30, Uncertain significance, not provided; Myopathy, centronuclear, 2
- Q19E (p.Gln19Glu), rs2105378861, ClinGen CA348376178, ClinVar RCV002007731, Ensembl rs2105378861, Uncertain significance, Myopathy, centronuclear, 2
- Q19H (p.Gln19His), rs142657993, ClinGen CA55353103, ClinVar RCV001986782, ESP rs142657993, REVEL 0.39, CADD 24.70, Uncertain significance, Myopathy, centronuclear, 2
- K20Q (p.Lys20Gln), TOPMed rs1681235591
- K21N (p.Lys21Asn), ExAC rs767681993, gnomAD rs767681993, REVEL 0.21, CADD 24.80, Uncertain significance
- K21Q (p.Lys21Gln), rs778087138, ClinGen CA55353084, ClinVar RCV002999532, TOPMed rs778087138, REVEL 0.14, CADD 23.80, Uncertain significance, Myopathy, centronuclear, 2
- L22R (p.Leu22Arg), gnomAD rs1383113147, REVEL 0.66, CADD 32.00
- T23I (p.Thr23Ile), TOPMed rs1681233957, gnomAD rs1681233957, REVEL 0.25, CADD 25.40
- R24C (p.Arg24Cys), rs2105378684, ClinGen CA348376115, ClinVar RCV003511446, UniProt VAR 081081, Uncertain significance, Myopathy, centronuclear, 2
- R24G (p.Arg24Gly), rs2105378684, ClinGen CA348376117, ClinVar RCV001912322, Ensembl rs2105378684, Uncertain significance, Myopathy, centronuclear, 2
- A25T (p.Ala25Thr), Ensembl rs1681232503, REVEL 0.47, CADD 25.40
- A25V (p.Ala25Val), TOPMed rs1033853814
- E27G (p.Glu27Gly), TOPMed rs1310221552, gnomAD rs1310221552, REVEL 0.30, CADD 25.70
- K28N (p.Lys28Asn), rs1681229622, ClinGen CA348376047, ClinVar RCV001348078, Ensembl rs1681229622, Uncertain significance, Myopathy, centronuclear, 2
- K28R (p.Lys28Arg), Ensembl rs200655302
- V29G (p.Val29Gly), cosmic curated COSV52119, ExAC rs773680350, gnomAD rs773680350
- K35N (p.Lys35Asn), rs121909273, ClinGen CA119458, NCI-TCGA Cosmic COSV9938, cosmic curated COSV99387, Pathogenic, Myopathy, centronuclear, 2
- T39P (p.Thr39Pro), ExAC rs748713505, gnomAD rs748713505
- K40T (p.Lys40Thr), ExAC rs781496643, gnomAD rs781496643, REVEL 0.61, CADD 24.50
- D41V (p.Asp41Val), TOPMed rs1388029180, gnomAD rs1388029180, REVEL 0.90, CADD 32.00
- Q43E (p.Gln43Glu), ExAC rs755092482, gnomAD rs755092482, REVEL 0.17, CADD 23.70
- Q43P (p.Gln43Pro), NCI-TCGA Cosmic COSV5212, cosmic curated COSV52121, Variant assessed as somatic; moderate impact.
- F44S (p.Phe44Ser), TOPMed rs1467098257, REVEL 0.90, CADD 32.00
- C47F (p.Cys47Phe), gnomAD rs1686655294
- C47R (p.Cys47Arg), gnomAD rs1054543683, REVEL 0.36, CADD 24.80, Uncertain significance, Myopathy, centronuclear, 2
- C47W (p.Cys47Trp), ExAC rs747090652, gnomAD rs747090652, Likely benign
- V48A (p.Val48Ala), NCI-TCGA Cosmic COSV9938, cosmic curated COSV99387, Variant assessed as somatic; moderate impact.
- V48I (p.Val48Ile), rs1394166082, ClinGen CA348370583, cosmic curated COSV52119, ClinVar RCV002647324, REVEL 0.25, CADD 25.70, Uncertain significance, Myopathy, centronuclear, 2
- F51C (p.Phe51Cys), TOPMed rs1184468227, gnomAD rs1184468227, REVEL 0.77, CADD 32.00, Uncertain significance, Myopathy, centronuclear, 2
- F51L (p.Phe51Leu), rs758601442, NCI-TCGA Cosmic COSV5212, cosmic curated COSV52120, ExAC rs758601442, REVEL 0.34, CADD 26.30, Variant assessed as somatic; moderate impact.
- N52I (p.Asn52Ile), rs369549551, ClinGen CA55327144, ClinVar RCV003127032, ClinVar RCV003619819, REVEL 0.41, CADD 31.00, Uncertain significance, not provided; Myopathy, centronuclear, 2
- N52S (p.Asn52Ser), rs369549551, ClinGen CA1857584, ClinVar RCV002009891, ESP rs369549551, REVEL 0.27, CADD 27.40, Uncertain significance, Myopathy, centronuclear, 2
- K53Q (p.Lys53Gln), NCI-TCGA Cosmic COSV9938, cosmic curated COSV99388, Variant assessed as somatic; moderate impact.
- Q54* (p.Gln54Ter), cosmic curated COSV52121, ExAC rs765035434, TOPMed rs765035434, gnomAD rs765035434, Uncertain significance
- Q54E (p.Gln54Glu), rs765035434, ClinGen CA1857583, ClinVar RCV003509133, ExAC rs765035434, REVEL 0.47, CADD 26.60, Uncertain significance, Myopathy, centronuclear, 2
- Q54R (p.Gln54Arg), TOPMed rs1163498945, gnomAD rs1163498945, REVEL 0.62, CADD 29.60
- L55V (p.Leu55Val), ExAC rs756941660, gnomAD rs756941660, REVEL 0.07, CADD 25.50
- T56M (p.Thr56Met), rs758360325, ClinGen CA1857563, NCI-TCGA Cosmic COSV9903, cosmic curated COSV99035, REVEL 0.02, CADD 19.60, Uncertain significance, Myopathy, centronuclear, 2; Inborn genetic diseases
- E57K (p.Glu57Lys), TOPMed rs1685792717, REVEL 0.41, CADD 23.20
- G58D (p.Gly58Asp), TOPMed rs1282156307, gnomAD rs1282156307, REVEL 0.47, CADD 25.50, Uncertain significance
- G58S (p.Gly58Ser), ExAC rs777814511, gnomAD rs777814511
- G58V (p.Gly58Val), rs1282156307, ClinGen CA348369910, cosmic curated COSV10458, ClinVar RCV000794378, Uncertain significance, Myopathy, centronuclear, 2
- T59A (p.Thr59Ala), cosmic curated COSV52117, Ensembl rs1573650224, REVEL 0.09, CADD 23.60
- T59I (p.Thr59Ile), ExAC rs755973108, TOPMed rs755973108, gnomAD rs755973108, REVEL 0.13, CADD 23.70
- T59P (p.Thr59Pro), Ensembl rs1573650224
- T59S (p.Thr59Ser), ExAC rs755973108, TOPMed rs755973108, gnomAD rs755973108, REVEL 0.06, CADD 19.30
- R60Q (p.Arg60Gln), rs1558835946, ClinGen CA348369886, NCI-TCGA Cosmic COSV5212, cosmic curated COSV52121, REVEL 0.14, CADD 24.50, Uncertain significance, Myopathy, centronuclear, 2
- R60W (p.Arg60Trp), cosmic curated COSV10959, TOPMed rs567993530, gnomAD rs567993530, REVEL 0.31, CADD 25.20, Uncertain significance, Myopathy, centronuclear, 2
- K63E (p.Lys63Glu), NCI-TCGA Cosmic COSV5211, cosmic curated COSV52116, Variant assessed as somatic; moderate impact.
- K63N (p.Lys63Asn), Ensembl rs1685788405
- D64N (p.Asp64Asn), Ensembl rs1685788064
- L65I (p.Leu65Ile), rs2105078067, ClinGen CA348369793, ClinVar RCV001889098, Ensembl rs2105078067, REVEL 0.17, CADD 23.80, Uncertain significance, Myopathy, centronuclear, 2
- R66L (p.Arg66Leu), TOPMed rs1685787289, REVEL 0.24, CADD 26.30
- R66P (p.Arg66Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R66Q (p.Arg66Gln), TOPMed rs1685787289, REVEL 0.18, CADD 26.30, Uncertain significance, Myopathy, centronuclear, 2
- R66W (p.Arg66Trp), rs767159511, ClinGen CA1857559, cosmic curated COSV10636, ClinVar RCV003486027, REVEL 0.18, CADD 27.10, Uncertain significance, Inborn genetic diseases; Myopathy, centronuclear, 2
- T67A (p.Thr67Ala), NCI-TCGA Cosmic COSV9938, cosmic curated COSV99388, Ensembl rs1685786940, Variant assessed as somatic; moderate impact.
- T67I (p.Thr67Ile), TOPMed rs1573650069, Uncertain significance, Myopathy, centronuclear, 2
- A70S (p.Ala70Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A70V (p.Ala70Val), TOPMed rs1210117688, REVEL 0.05, CADD 22.80
- S71F (p.Ser71Phe), TOPMed rs1685785345, REVEL 0.34, CADD 24.70
- A74V (p.Ala74Val), gnomAD rs1466528785, REVEL 0.28, CADD 24.50, Uncertain significance, Myopathy, centronuclear, 2
- M75I (p.Met75Ile), gnomAD rs1685760627, REVEL 0.47, CADD 23.20
- M75T (p.Met75Thr), rs1024658796, ClinGen CA55321794, ClinVar RCV001350205, TOPMed rs1024658796, REVEL 0.56, CADD 23.40, Uncertain significance, Myopathy, centronuclear, 2
- H76R (p.His76Arg), ExAC rs764375566, TOPMed rs764375566, gnomAD rs764375566, REVEL 0.35, CADD 23.60
- H76Y (p.His76Tyr), Ensembl rs1685760285
- E77K (p.Glu77Lys), rs1685759135, ClinGen CA348369606, ClinVar RCV001245547, NCI-TCGA TCGA novel, Uncertain significance, Myopathy, centronuclear, 2
- A78T (p.Ala78Thr), Ensembl rs2105076138
- S79F (p.Ser79Phe), rs1377099769, ClinGen CA348369577, ClinVar RCV001966428, TOPMed rs1377099769, REVEL 0.70, CADD 31.00, Uncertain significance, Myopathy, centronuclear, 2
- K80E (p.Lys80Glu), Ensembl rs1573648631
- L82V (p.Leu82Val), gnomAD rs1212299957
- N83I (p.Asn83Ile), TOPMed rs1363900230, gnomAD rs1363900230, REVEL 0.03, CADD 23.10, Uncertain significance
- N83S (p.Asn83Ser), TOPMed rs1363900230, gnomAD rs1363900230, REVEL 0.03, CADD 17.60, Uncertain significance, Inborn genetic diseases
- E84D (p.Glu84Asp), ExAC rs772566024, gnomAD rs772566024, Likely benign
- C85Y (p.Cys85Tyr), TOPMed rs1685755597
- Q87* (p.Gln87Ter), rs2105075896, ClinGen CA348369486, ClinVar RCV002015089, Ensembl rs2105075896, CADD 41.00, Uncertain significance
- Q87R (p.Gln87Arg), gnomAD rs1436882543, REVEL 0.08, CADD 22.70
- V89L (p.Val89Leu), TOPMed rs1573648478
- Y90C (p.Tyr90Cys), rs1391982523, NCI-TCGA Cosmic COSV9938, cosmic curated COSV99387, gnomAD rs1391982523, REVEL 0.66, CADD 27.00, Variant assessed as somatic; moderate impact.
- E91D (p.Glu91Asp), NCI-TCGA Cosmic COSV5212, cosmic curated COSV52120, Variant assessed as somatic; moderate impact.
- E91K (p.Glu91Lys), gnomAD rs1292748182, REVEL 0.31, CADD 23.30
- E91V (p.Glu91Val), Ensembl rs1685753109
- P92L (p.Pro92Leu), gnomAD rs1458308545, REVEL 0.32, CADD 23.40
- D93E (p.Asp93Glu), rs770994335, ClinGen CA348369413, ClinVar RCV001238014, ClinVar RCV001760256, REVEL 0.09, CADD 12.00, Uncertain significance, Myopathy, centronuclear, 2; not provided
- D93N (p.Asp93Asn), rs774273606, ClinGen CA1857530, cosmic curated COSV52120, ClinVar RCV001327887, REVEL 0.27, CADD 22.70, Uncertain significance, Myopathy, centronuclear, 2
- D93Y (p.Asp93Tyr), rs774273606, ClinGen CA1857531, ClinVar RCV001315537, ClinVar RCV005306392, REVEL 0.32, CADD 24.30, Uncertain significance, Inborn genetic diseases; Myopathy, centronuclear, 2
- W94C (p.Trp94Cys), Ensembl rs2105075506
- W94R (p.Trp94Arg), gnomAD rs1426802434
- P95L (p.Pro95Leu), rs1685750277, ClinGen CA348369398, ClinVar RCV003620197, TOPMed rs1685750277, REVEL 0.15, CADD 18.10, Uncertain significance, Myopathy, centronuclear, 2
- P95S (p.Pro95Ser), ExAC rs749504481, gnomAD rs749504481, REVEL 0.15, CADD 18.10
- G96A (p.Gly96Ala), NCI-TCGA Cosmic COSV9938, Variant assessed as somatic; moderate impact.
- G96C (p.Gly96Cys), ExAC rs769724273, TOPMed rs769724273, gnomAD rs769724273, REVEL 0.73, CADD 25.50, Uncertain significance
- G96R (p.Gly96Arg), ExAC rs769724273, TOPMed rs769724273, gnomAD rs769724273, REVEL 0.65, CADD 25.00, Uncertain significance
- G96S (p.Gly96Ser), rs769724273, ClinGen CA1857526, ClinVar RCV000819262, ClinVar RCV004797882, REVEL 0.48, CADD 24.70, Uncertain significance, Myopathy, centronuclear, 2; Inborn genetic diseases; not provided
- G96V (p.Gly96Val), Ensembl rs374028200
- R97G (p.Arg97Gly), TOPMed rs1251472613, gnomAD rs1251472613, REVEL 0.30, CADD 24.60, Uncertain significance, Myopathy, centronuclear, 2
- D98G (p.Asp98Gly), cosmic curated COSV10608, Ensembl rs1573648064
- D98N (p.Asp98Asn), cosmic curated COSV10458, TOPMed rs1307310674
- D98Y (p.Asp98Tyr), NCI-TCGA Cosmic COSV5211, cosmic curated COSV52116, Variant assessed as somatic; moderate impact.
- E99G (p.Glu99Gly), Ensembl rs1685747063, REVEL 0.26, CADD 24.90
- A100E (p.Ala100Glu), gnomAD rs1267741868, REVEL 0.17, CADD 23.00
- A104T (p.Ala104Thr), rs754932468, ClinGen CA1857523, cosmic curated COSV10959, ClinVar RCV001369553, REVEL 0.11, CADD 22.00, Uncertain significance, Myopathy, centronuclear, 2
- E105K (p.Glu105Lys), rs1685745258, ClinGen CA348369308, ClinVar RCV001215101, Ensembl rs1685745258, REVEL 0.32, CADD 23.50, Uncertain significance, Myopathy, centronuclear, 2
- N106=, NCI-TCGA Cosmic COSV9938, Variant assessed as somatic; low impact.
- N106K (p.Asn106Lys), Ensembl rs1281529982
- N106S (p.Asn106Ser), gnomAD rs1172180320, REVEL 0.16, CADD 22.20
- N107K (p.Asn107Lys), 1000Genomes rs529323298, ExAC rs529323298, TOPMed rs529323298, gnomAD rs529323298, REVEL 0.09, CADD 6.07, Likely benign
- D108E (p.Asp108Glu), TOPMed rs1218784993, REVEL 0.20, CADD 22.30
- D108N (p.Asp108Asn), rs532260569, ClinGen CA55321367, ClinVar RCV001928983, TOPMed rs532260569, REVEL 0.28, CADD 23.70, Uncertain significance, Myopathy, centronuclear, 2; Inborn genetic diseases
- L109M (p.Leu109Met), gnomAD rs931469037, REVEL 0.03, CADD 23.40
- L110Q (p.Leu110Gln), rs2105070437, ClinGen CA348369160, ClinVar RCV002018222, Ensembl rs2105070437, Uncertain significance, Myopathy, centronuclear, 2
- M112I (p.Met112Ile), gnomAD rs981056581
- D113H (p.Asp113His), NCI-TCGA Cosmic COSV5211, cosmic curated COSV52117, Variant assessed as somatic; moderate impact.
- H115Y (p.His115Tyr), NCI-TCGA TCGA novel, TOPMed rs1685676424, Variant assessed as somatic; moderate impact.
- Q121H (p.Gln121His), ExAC rs757907934, TOPMed rs757907934, gnomAD rs757907934, REVEL 0.09, CADD 23.20, Uncertain significance, Myopathy, centronuclear, 2
- Q121R (p.Gln121Arg), cosmic curated COSV10877, TOPMed rs1185043515, gnomAD rs1185043515, REVEL 0.10, CADD 24.10
- A122G (p.Ala122Gly), ExAC rs745382388, gnomAD rs745382388
- A122V (p.Ala122Val), ExAC rs745382388, gnomAD rs745382388, REVEL 0.29, CADD 24.30
- T125* (p.Thr125Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- M126I (p.Met126Ile), gnomAD rs1227561308, REVEL 0.18, CADD 23.60
- M126V (p.Met126Val), rs1258696983, ClinGen CA348368889, ClinVar RCV003143794, gnomAD rs1258696983, REVEL 0.24, CADD 23.30, Uncertain significance, Myopathy, centronuclear, 2
- D127G (p.Asp127Gly), rs1329715143, ClinGen CA348368872, ClinVar RCV003620341, TOPMed rs1329715143, REVEL 0.37, CADD 25.70, Uncertain significance, Myopathy, centronuclear, 2
- T128M (p.Thr128Met), rs756882994, NCI-TCGA Cosmic COSV9938, cosmic curated COSV99388, ExAC rs756882994, REVEL 0.42, CADD 24.30, Variant assessed as somatic; moderate impact.
- Y129H (p.Tyr129His), rs2105069995, ClinGen CA348368849, ClinVar RCV002031138, Ensembl rs2105069995, Uncertain significance, Myopathy, centronuclear, 2
- L130Q (p.Leu130Gln), TOPMed rs1392736794, gnomAD rs1392736794, REVEL 0.53, CADD 24.90
- Q132* (p.Gln132Ter), rs1385213884, NCI-TCGA Cosmic COSV5211, cosmic curated COSV52116, gnomAD rs1385213884, CADD 45.00, Variant assessed as somatic; high impact.
- F133L (p.Phe133Leu), NCI-TCGA Cosmic COSV9938, cosmic curated COSV99388, Variant assessed as somatic; moderate impact.
- D135N (p.Asp135Asn), rs766894632, ClinGen CA1857493, NCI-TCGA Cosmic COSV5212, cosmic curated COSV52120, REVEL 0.37, CADD 24.40, Uncertain significance, Myopathy, centronuclear, 2; Inborn genetic diseases
- I136N (p.Ile136Asn), Ensembl rs1685667719
- R139C (p.Arg139Cys), ExAC rs777348282, TOPMed rs777348282, gnomAD rs777348282, REVEL 0.37, CADD 25.70
- R139H (p.Arg139His), rs755355125, ClinGen CA1857478, NCI-TCGA Cosmic COSV5211, ClinVar RCV000431154, REVEL 0.54, CADD 30.00, Uncertain significance, not provided; Myopathy, centronuclear, 2
- R139L (p.Arg139Leu), rs755355125, NCI-TCGA Cosmic COSV5211, cosmic curated COSV52116, ExAC rs755355125, REVEL 0.40, CADD 25.00, Uncertain significance
- I140L (p.Ile140Leu), rs1407049344, ClinGen CA348368062, ClinVar RCV001242127, TOPMed rs1407049344, REVEL 0.35, CADD 27.70, Uncertain significance, Myopathy, centronuclear, 2
- I140V (p.Ile140Val), TOPMed rs1407049344, REVEL 0.21, CADD 23.80, Uncertain significance
- A141V (p.Ala141Val), TOPMed rs1685518327, REVEL 0.42, CADD 31.00
- R143Q (p.Arg143Gln), ExAC rs780463774, gnomAD rs780463774, REVEL 0.75, CADD 31.00, Uncertain significance, Myopathy, centronuclear, 2
- R143W (p.Arg143Trp), TOPMed rs1685517780, REVEL 0.68, CADD 26.90, Uncertain significance, Myopathy, centronuclear, 2
- G144E (p.Gly144Glu), gnomAD rs1187515545, REVEL 0.23, CADD 24.50
- G144R (p.Gly144Arg), rs1685516968, ClinGen CA348367997, ClinVar RCV001314744, Ensembl rs1685516968, Uncertain significance, Myopathy, centronuclear, 2
- R145C (p.Arg145Cys), rs1249621033, ClinGen CA348367975, NCI-TCGA Cosmic COSV5211, ClinVar RCV000754844, REVEL 0.52, CADD 28.40, Likely pathogenic, Myopathy, centronuclear, 2
- R145H (p.Arg145His), rs1219115067, ClinGen CA348367972, ClinVar RCV001208067, gnomAD rs1219115067, REVEL 0.39, CADD 25.20, Uncertain significance, Myopathy, centronuclear, 2
- K146Q (p.Lys146Gln), NCI-TCGA Cosmic COSV9938, cosmic curated COSV99388, Variant assessed as somatic; moderate impact.
- V148R (p.Val148Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- D149G (p.Asp149Gly), NCI-TCGA Cosmic COSV9938, cosmic curated COSV99388, Variant assessed as somatic; moderate impact.
- D151G (p.Asp151Gly), NCI-TCGA Cosmic COSV9938, cosmic curated COSV99387, Variant assessed as somatic; moderate impact., in CNM2
- D151N (p.Asp151Asn), rs121909274, ClinGen CA119459, NCI-TCGA Cosmic COSV5211, cosmic curated COSV52115, REVEL 0.85, CADD 29.10, Pathogenic, Myopathy, centronuclear, 2
- A153T (p.Ala153Thr), gnomAD rs1361643970, REVEL 0.35, CADD 24.40
- R154L (p.Arg154Leu), TOPMed rs267606681, Uncertain significance, in CNM2
- R154Q (p.Arg154Gln), rs267606681, ClinGen CA119462, ClinVar RCV000008798, UniProt VAR 081083, REVEL 0.69, CADD 29.10, Conflicting interpretations, Myopathy, centronuclear, 2
- R154W (p.Arg154Trp), rs761914168, ClinGen CA1857472, ClinVar RCV000811248, ExAC rs761914168, REVEL 0.57, CADD 29.00, Uncertain significance, Myopathy, centronuclear, 2
- Y157H (p.Tyr157His), rs1553466026, ClinGen CA348367773, ClinVar RCV000545195, ClinVar RCV001770423, REVEL 0.43, CADD 27.40, Uncertain significance, Myopathy, centronuclear, 2; not provided
- E158K (p.Glu158Lys), rs764377144, ClinGen CA1857470, ClinVar RCV000636907, ExAC rs764377144, REVEL 0.18, CADD 24.20, Uncertain significance, Myopathy, centronuclear, 2
- S159Y (p.Ser159Tyr), ESP rs371755655, TOPMed rs371755655, gnomAD rs371755655, REVEL 0.23, CADD 26.60
- L160F (p.Leu160Phe), rs1685511003, ClinGen CA348367727, ClinVar RCV001242608, ClinVar RCV002564035, REVEL 0.42, CADD 26.30, Uncertain significance, Myopathy, centronuclear, 2; Inborn genetic diseases
- L160R (p.Leu160Arg), TOPMed rs1039877281, gnomAD rs1039877281, REVEL 0.41, CADD 27.90
- A163G (p.Ala163Gly), gnomAD rs1330946461, REVEL 0.08, CADD 22.50, Uncertain significance, Inborn genetic diseases
- A163S (p.Ala163Ser), TOPMed rs1210981592, REVEL 0.06, CADD 17.80
- E168D (p.Glu168Asp), TOPMed rs1685508719
- A169D (p.Ala169Asp), rs775335446, ClinGen CA1857468, ClinVar RCV003510048, ExAC rs775335446, REVEL 0.08, CADD 22.60, Uncertain significance, Myopathy, centronuclear, 2
- I171T (p.Ile171Thr), Ensembl rs2105058186
- K173T (p.Lys173Thr), TOPMed rs1685507855
- S176L (p.Ser176Leu), rs776075897, ClinGen CA1857441, cosmic curated COSV52117, ClinVar RCV001037966, REVEL 0.18, CADD 25.00, Uncertain significance, Myopathy, centronuclear, 2
- A182S (p.Ala182Ser), ExAC rs779607755, TOPMed rs779607755, gnomAD rs779607755, Uncertain significance
- A182T (p.Ala182Thr), rs779607755, ClinGen CA1857438, ClinVar RCV001342312, ExAC rs779607755, REVEL 0.13, CADD 24.80, Uncertain significance, Myopathy, centronuclear, 2
- A182V (p.Ala182Val), NCI-TCGA Cosmic COSV5211, NCI-TCGA Cosmic COSV9938, cosmic curated COSV99388, Variant assessed as somatic; moderate impact.
- P183L (p.Pro183Leu), cosmic curated COSV10726, Ensembl rs1685394910, Uncertain significance, Inborn genetic diseases
- Q184* (p.Gln184Ter), NCI-TCGA Cosmic COSV9938, ExAC rs777940512, TOPMed rs777940512, gnomAD rs777940512, CADD 43.00, Uncertain significance
Public BIN1 analysis runs
- BIN1 analysis run — BIN1 (836 variants) — completed 2026-08-21